The fact that most human cancer cell lines derived from clinical specimens express NKG2D ligands has been attributed to their roles in stimulating inhibitory receptors on NK cells and suppressing anti-tumor immunity through soluble NKG2D ligands [38]. This evidence concerns the gene KLRK1 and cancer.